Preliminary Study on the Safety of a New Vaccine Against Canine Babesiosis Containing Soluble Parasitic Antigen (SPA)
The aim of this study was to assess the safety of a new vaccine, containing soluble parasitic antigen (SPA), against canine babesiosis. Fifteen dogs were included in the experiment. Five controls received only the adjuvant and 10 dogs were vaccinated with Babesia canis canis SPA twice, at a two week...
Main Authors: | Adaszek Łukasz, Wernicka-Furmaga Romana, Winiarczyk Stanisław |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2012-06-01
|
Series: | Bulletin of the Veterinary Institute in Pulawy |
Subjects: | |
Online Access: | https://doi.org/10.2478/v10213-012-0026-0 |
Similar Items
-
Quantitative Changes in Selected Lymphocyte Subpopulations after Administration of a Soluble Parasitic Antigen of Babesia Canis to Dogs
by: Adaszek Łukasz, et al.
Published: (2013-03-01) -
Identification of the causative agent of canine babesiosis in the Kirov Region
by: O. O. Skornyakova
Published: (2021-06-01) -
Peculiarities of Dog Babesiosis Distribution in Kyiv City
by: Semenko O. V., et al.
Published: (2017-12-01) -
Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs
by: Thomas Geurden, et al.
Published: (2017-09-01) -
Blood pressure changes in dogs with babesiosis
by: L.S. Jacobson, et al.
Published: (2000-07-01)